NO944934D0 - Hemming av vasomotoriske symptomer og tilhörende psykologiske forstyrrelser i forbindelse med post-menopausalt syndrom - Google Patents
Hemming av vasomotoriske symptomer og tilhörende psykologiske forstyrrelser i forbindelse med post-menopausalt syndromInfo
- Publication number
- NO944934D0 NO944934D0 NO944934A NO944934A NO944934D0 NO 944934 D0 NO944934 D0 NO 944934D0 NO 944934 A NO944934 A NO 944934A NO 944934 A NO944934 A NO 944934A NO 944934 D0 NO944934 D0 NO 944934D0
- Authority
- NO
- Norway
- Prior art keywords
- inhibition
- post
- vasomotor symptoms
- psychological disorders
- menopausal syndrome
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/173,502 US5534526A (en) | 1993-12-21 | 1993-12-21 | Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO944934D0 true NO944934D0 (no) | 1994-12-19 |
| NO944934L NO944934L (no) | 1995-06-22 |
Family
ID=22632322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO944934A NO944934L (no) | 1993-12-21 | 1994-12-19 | Hemming av vasomotoriske symptomer og tilhörende psykologiske forstyrrelser i forbindelse med post-menopausalt syndrom |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5534526A (no) |
| EP (1) | EP0659415A3 (no) |
| JP (1) | JPH07196500A (no) |
| KR (1) | KR950016730A (no) |
| CN (1) | CN1108093A (no) |
| AU (1) | AU691844B2 (no) |
| CA (1) | CA2138499A1 (no) |
| CZ (1) | CZ320994A3 (no) |
| HU (1) | HUT71478A (no) |
| IL (1) | IL112038A0 (no) |
| NO (1) | NO944934L (no) |
| NZ (1) | NZ270168A (no) |
| PH (1) | PH31327A (no) |
| RU (1) | RU94045278A (no) |
| ZA (1) | ZA9410093B (no) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6417198B1 (en) | 1993-12-21 | 2002-07-09 | Eli Lilly And Company | Methods of inhibiting CNS problems in post-menopausal women |
| US5596106A (en) * | 1994-07-15 | 1997-01-21 | Eli Lilly And Company | Cannabinoid receptor antagonists |
| US5512296A (en) * | 1994-08-22 | 1996-04-30 | Eli Lilly And Company | Methods for inhibiting neuronal damage |
| IL120266A (en) | 1996-02-28 | 2005-05-17 | Pfizer | Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions |
| TW442286B (en) * | 1996-02-28 | 2001-06-23 | Pfizer | New therapeutic uses of estrogen agonists |
| US6110942A (en) * | 1996-06-17 | 2000-08-29 | Eli Lilly And Company | Method for minimizing the uterotrophic effect of droloxifene |
| ZA982877B (en) * | 1997-04-09 | 1999-10-04 | Lilly Co Eli | Treatment of central nervous system disorders with selective estrogen receptor modulators. |
| WO1998046588A2 (en) | 1997-04-11 | 1998-10-22 | Neorx Corporation | Compounds and therapies for the prevention of vascular and non-vascular pathologies |
| US6008232A (en) * | 1997-08-20 | 1999-12-28 | Eli Lilly And Company | Methods for preventing headaches |
| US6096781A (en) | 1997-11-14 | 2000-08-01 | Eli Lilly And Company | 2-arylbenzo[B]thiophenes useful for the treatment of estrogen deprivation syndrome |
| BR9908431A (pt) * | 1998-03-02 | 2000-10-31 | Lilly Co Eli | Cloridrato de fluoxetina para diminuição de fogalhos |
| US6288108B1 (en) | 1998-06-16 | 2001-09-11 | Eli Lilly And Company | Methods for increasing levels of acetylcholine |
| JP2002518329A (ja) | 1998-06-16 | 2002-06-25 | イーライ・リリー・アンド・カンパニー | アセチルコリンレベルを増加させる方法 |
| US6258826B1 (en) | 1998-10-13 | 2001-07-10 | Eli Lilly And Company | Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome |
| ATE301129T1 (de) | 1999-05-04 | 2005-08-15 | Strakan Int Ltd | Androgen glykoside und die androgenische aktivität davon |
| EP1608357A4 (en) * | 2003-03-31 | 2008-03-26 | Xenoport Inc | TREATMENT OR PREVENTION OF HITZEWALLUNGEN USING PRODRUGS OF GABA ANALOGUE |
| AU2009274022B2 (en) | 2008-07-22 | 2016-06-02 | Menogenix, Inc. | Compositions and methods for treating symptoms associated with menopause, hormonal variations and arthritis |
| US9151289B2 (en) | 2008-08-21 | 2015-10-06 | Cummins Inc. | Fuel pump |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE637389A (no) * | 1962-09-13 | |||
| US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
| US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
| US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
| US4729999A (en) * | 1984-10-12 | 1988-03-08 | Bcm Technologies | Antiestrogen therapy for symptoms of estrogen deficiency |
| US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
| JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
| US5391557A (en) * | 1993-10-15 | 1995-02-21 | Eli Lilly And Company | Methods for the treatment of peri-menopausal syndrome |
-
1993
- 1993-12-21 US US08/173,502 patent/US5534526A/en not_active Expired - Fee Related
-
1994
- 1994-12-19 HU HU9403662A patent/HUT71478A/hu unknown
- 1994-12-19 JP JP6314541A patent/JPH07196500A/ja active Pending
- 1994-12-19 CN CN94119740A patent/CN1108093A/zh active Pending
- 1994-12-19 KR KR1019940034921A patent/KR950016730A/ko not_active Application Discontinuation
- 1994-12-19 NO NO944934A patent/NO944934L/no unknown
- 1994-12-19 AU AU81548/94A patent/AU691844B2/en not_active Ceased
- 1994-12-19 PH PH49586A patent/PH31327A/en unknown
- 1994-12-19 CA CA002138499A patent/CA2138499A1/en not_active Abandoned
- 1994-12-19 IL IL11203894A patent/IL112038A0/xx unknown
- 1994-12-19 NZ NZ270168A patent/NZ270168A/en unknown
- 1994-12-19 ZA ZA9410093A patent/ZA9410093B/xx unknown
- 1994-12-19 EP EP94309473A patent/EP0659415A3/en not_active Withdrawn
- 1994-12-19 RU RU94045278/14A patent/RU94045278A/ru unknown
- 1994-12-19 CZ CZ943209A patent/CZ320994A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA9410093B (en) | 1996-06-19 |
| CA2138499A1 (en) | 1995-06-22 |
| IL112038A0 (en) | 1995-03-15 |
| NO944934L (no) | 1995-06-22 |
| EP0659415A2 (en) | 1995-06-28 |
| CN1108093A (zh) | 1995-09-13 |
| AU8154894A (en) | 1995-06-29 |
| NZ270168A (en) | 1997-07-27 |
| JPH07196500A (ja) | 1995-08-01 |
| EP0659415A3 (en) | 1995-10-11 |
| AU691844B2 (en) | 1998-05-28 |
| US5534526A (en) | 1996-07-09 |
| CZ320994A3 (en) | 1995-08-16 |
| KR950016730A (ko) | 1995-07-20 |
| RU94045278A (ru) | 1996-11-10 |
| HU9403662D0 (en) | 1995-02-28 |
| PH31327A (en) | 1998-07-06 |
| HUT71478A (en) | 1995-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO944934D0 (no) | Hemming av vasomotoriske symptomer og tilhörende psykologiske forstyrrelser i forbindelse med post-menopausalt syndrom | |
| NO944164D0 (no) | Fremgangsmåte for fremstilling og anvendelse av en HCl-adsorbent | |
| NO992782D0 (no) | FremgangsmÕte for Õ forsterke s°tningskraften og forbedre smaken av s°tningsmidler med h°y intensitet | |
| NO930044L (no) | Fremgangsmaate til vurdering av formasjoner og borkronetilstander | |
| DE69416668D1 (de) | Unterscheidung zwischen stationären und nicht-stationären signalen | |
| NO922268D0 (no) | Borkrone med koniske rullemeisler | |
| NO20014674D0 (no) | Fremgangsmåte for behandling av neurologiske og neuropsykiatriske forstyrrelser | |
| DE69421498D1 (de) | Unterscheidung zwischen stationären und nicht-stationären signalen | |
| DK0452262T3 (da) | Presset tablet med reduceret kalorieindhold og forbedret fornemmelse i munden | |
| NO961790D0 (no) | Kombinasjon av apparatsokkel og innsatselement | |
| DE69528165D1 (de) | Transdermal verabreichbare grundlage und daraus hergestelltes transdermal verabreichbares arzneimittel | |
| NO995469L (no) | Fremgangsmåte til behandling av mentale sykdommer hos pattedyr og en sammensetning derfor | |
| NO920880D0 (no) | Fremgangsmaate og anordning for katalytisk omdannelse av oksygenholdige hydrokarboner | |
| NO961226D0 (no) | Blandinger for forebyggelse og behandling av viralinduserte tumorer | |
| NO932342D0 (no) | Fremgangsmaate og innretning for fremstilling av pakker med amorfe staalstrimler for produksjon av transformatorskjermer | |
| NO942531D0 (no) | Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener | |
| NO953089L (no) | Steroider for behandling av klimakterieplager | |
| NO944910D0 (no) | Fremgangsmåte for å inhibere obsessive-kompulsive tilstander og spiseforstyrrelser | |
| EP0525469A3 (en) | Procedure of but-welding two pipe ends and device for the execution of the procedure | |
| FR2632859B1 (fr) | Dispositif podologique pour la correction des troubles et des affections du tonus neuromusculaire de posture | |
| ITMI922657A0 (it) | Composizione terapeutica per uso rettale a base di flunisolide e/o deirelativi esteri per il trattamento di disordini intestinali a carattere infiammatorio | |
| KR940022215U (ko) | 키(key) 톱(top)의 삐뚤어짐 방지장치 | |
| NO923663L (no) | Fremgangsmåte og innretning for installasjon av instrument på undervannsinstallasjon | |
| NO932385D0 (no) | Anordning for registrering av overgangssoner og nivaaer | |
| NO163155C (no) | Fremgangsmaate og anordning for isetting av toppringer i lampeskjermer. |